Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease

By sjmartinez • February 26, 2025

Krasuski RA, Tobore T, Studer S, Jansa P, Sitbon O, Hoeper MM, Channick R, Gaine S, Lang I, Chin K, Pulido T, Mehta S, Torbicki A, Sastry B, Tang X, McLaughlin V, Reardon LC. Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease. JACC Adv. 2025 Feb 24;4(3):101626. doi: 10.1016/j.jacadv.2025.101626. Epub ahead of print. PMID: 39999520.

Tags: Cardiology/Epi, COMPASS-2, congenital heart disease, GRIPHON, Pooled analysis, Publications, pulmonary arterial hypertension, Pulmonary, Critical Care & Sleep Medicine, SERAPHIN

Related Posts

Air Pollution Triggers Metabolomic Signature of Mitochondrial Dysfunction in Mice and Humans: Implications for Cardiovascular Disease Development

Lin Y, Qiu X, Gupta R, Ramanathan G, Lu X, Yin F, Fiehn O, Zhang JJ, Kaufman JD, Zhu Y, Rosenfeld M, Araujo JA. Air[...]

Lamin B1 Coordinates the Assembly of the Nuclear Lamina

Kim JR, Kim PH, Tu Y, Carroll J, Koerner JP, Young SG, Fong LG. Lamin B1 Coordinates the Assembly of the Nuclear Lamina. J Cell[...]

Regulators of Mineralization and Long-Term Progression of Aortic Valve and Mitral Annular Calcification: MESA

Bortnick AE, Naveed M, Fu X, Shea K, Kestenbaum B, de Boer I, Ix JH, Kim R, Hamerton E, Kankaria R, Tracy RP, Tsai M,[...]